Instrumento Inactivo

Otros idiomas Novo Nordisk A/S Xetra

Acciones

DK0060102614

Precio de cierre Xetra Otros sitios de cotización
- ^EUR	-

31/05	Zealand Pharma obtiene el respaldo del panel de la UE para el tratamiento de la hipoglucemia grave	MT
30/05	El gobierno danés aplica normas de subvención más estrictas para los medicamentos contra la diabetes	MT

Otros idiomas

Desbloquee todas las noticias sobre todas las empresas: ¡No vuelvas a perderse una oportunidad de inversión rentable!

Inscripción 100% Gratuita

Zealand Pharma Secures EU Panel Backing for Severe Hypoglycemia Treatment	31/05
Danish Government Implements Stricter Subsidy Rules for Diabetes Drugs	30/05
Wegovy maker Novo Nordisk sues nine spas, clinics and pharmacies over copycat drugs	30/05
NOVO NORDISK : Buy rating by Goldman Sachs	30/05
EARNINGS AND TRADING: First Tin "consolidates" holdings in Taronga	29/05
Catalent Shareholders Approve Deal With Novo Holdings	29/05
Catalent stockholders approve deal with Novo Holdings	29/05
Sector Update: Health Care Stocks Fall Late Afternoon	28/05
Sector Update: Health Care Stocks Retreat Tuesday Afternoon	28/05
Previsiones de venta de medicamentos para adelgazar suben a 150.000 millones de dólares	28/05
Novo Nordisk Tells US Senate Health Committee Chair Sanders It Only Keeps 60% of Ozempic, Wegovy List Price	28/05
Novo Nordisk's Boost to Danish Employment Levels More than Expected, Economic Councils Says	28/05
Novo Nordisk Said to Defend Drug Prices Amid Heat from US Lawmakers	28/05
Weight-loss drug forecasts jump to $150 billion as supply grows	28/05
NOVO NORDISK : Deutsche Bank reaffirms its Buy rating	28/05
Bolsa de Madrid: Wall Street y la City ya no responden	27/05
Los usuarios de Wegovy tienen menos problemas de salud renales, según análisis de un estudio de Novo	25/05
Wegovy users have less kidney-related health problems, analysis of Novo study finds	25/05
US FDA panel votes against use of Novo Nordisk's weekly insulin in type 1 diabetes patients	24/05
Top Midday: Intuit, Workday Shares Tumble on Lowered Guidance; Ozempic Reduces Kidney Disease Events, Deaths From Cardiovascular Causes; NHTSA Finds 9 Additional Incidents Tied to Waymo	24/05